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Stanniocalcin 2 (STC2) is a fish protein that controls body Ca2+ and phosphate
metabolism. STC2 has also been described in mammals, and as platelet function highly
depends on both extracellular and intracellular Ca2+, we have explored its expression
and function in these cells. STC2−/− mice exhibit shorter tail bleeding time than WT
mice. Platelets from STC2-deficient mice showed enhanced aggregation, as well as
enhanced Ca2+ mobilization in response to the physiological agonist thrombin (Thr)
and the diacylglycerol analog, OAG, a selective activator of the non-capacitative Ca2+
entry channels. Interestingly, platelets from STC2−/− mice exhibit attenuated interaction
between STIM1 and Orai1 in response to Thr, thus suggesting that STC2 is required
for Thr-evoked STIM1-Orai1 interaction and the subsequent store-operated Ca2+ entry
(SOCE). We have further assessed possible changes in the expression of the most
relevant channels involved in non-capacitative Ca2+ entry in platelets. Then, protein
expression of Orai3, TRPC3 and TRPC6 were evaluated by Western blotting, and the
results revealed that while the expression of Orai3 was enhanced in the STC2-deficient
mice, others like TRPC3 and TRPC6 remains almost unaltered. Summarizing, our results
provide for the first time evidence for a role of STC2 in platelet physiology through the
regulation of agonist-induced Ca2+ entry, which might be mediated by the regulation of
Orai3 channel expression.
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INTRODUCTION
Platelets are anucleated cells that play a relevant role in haemostasis. Attenuation of platelet
function causes spontaneous browsing and bleeding. In contrast, hyperaggregability might lead
to both macrothrombosis (observed in ictus or stroke) and microthrombosis (as detected in certain
forms of retinopathy and nephropathy), as well as other cardiovascular disorders (Gue and Gorog,
2017; Malerba et al., 2017; Mancuso and Santagostino, 2017; Scherlinger et al., 2017). Hence,
understanding the mechanisms underlying platelet function would be of relevance to prevent
platelet-related complications linked to certain diseases. It is well known that platelet function
strongly depends on changes in the intracellular calcium concentration ([Ca2+]c). Agonist might
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increase [Ca2+]c either by releasing Ca
2+ from the intracellular
stores or inducing Ca2+ entry from the extracellular medium.
Regarding Ca2+ entry, store-operated calcium entry (SOCE) is
a major mechanism activated by receptor occupation (Redondo
and Rosado, 2015; Berna-Erro et al., 2016). With respect to SOCE
activation, it is well known that a reduction in the endoplasmic
reticulum Ca2+ content is detected by STIM1, which undergoes
a conformational change and translocation to endoplasmic
reticulum/plasma membrane (ER/PM) junctions in order to
communicate with and activates Orai1 (Schindl et al., 2009;
Scrimgeour et al., 2014; Shim et al., 2015). Since new regulators of
the core components conforming the structure of SOCE channels
has been described, more research on this topic is required
for fully understanding the mechanism that controls Ca2+
entry from the extracellular medium. Orai1 is the pore-forming
subunit of the highly Ca2+ selective calcium release-activated
calcium (CRAC) channels (Prakriya et al., 2006). Additionally,
STIM1 also activates a non-selective current mediated by store-
operated calcium (SOC) channels, which consist on Orai1 and
TRPC1 subunits (Desai et al., 2015). SOCE has been found to
be modulated by a number of regulatory proteins that fine-tune
Ca2+ influx in order to generate appropriate Ca2+ signals, and
can be regulated by direct protein interaction (like the cytosolic
Ca2+ sensor, calmodulin; Galan et al., 2011; Li et al., 2017).
In addition to SOCE, non-capacitative Ca2+ entry has also
been reported in platelets, where TRPC3, TRPC6 and Orai3
have been found to play an important role (Berna-Erro et al.,
2012; Harper et al., 2013). Concerning Orai3, this channel is
able to form store independent channels with Orai1 regulated
by arachidonate, the arachidonic acid-regulated calcium-selective
(Mignen et al., 2008; Demuro et al., 2011; Zhang et al., 2014;
Albarran et al., 2016) as well as the supposedly homomeric
channels regulated by 2-aminoethoxydiphenyl borate (Demuro
et al., 2011; Amcheslavsky et al., 2014). TRPC6 has been found
to be involved in both SOCE and non-capacitive Ca2+ entry in
human platelets and TRPC3 was reported to participate in non-
capacitative Ca2+ entry in human and murine platelets (Zbidi
et al., 2009; Harper et al., 2013).
Stanniocalcin 2 (STC2) was first identified as a fish protein
involved in calcium and phosphate homeostasis (Wagner et al.,
1998a,b). In mammals, indirect evidence suggest that STC2 has
a relevant regulatory role on phosphate physiology. Contrary,
its regulatory function in Ca2+ is limited to the intracellular
environments, as evidenced in bone tissue (Ishibashi and Imai,
2002). In addition, STC2 is overexpressed by cancer cells (Na
et al., 2015; Wang et al., 2015). Mammalian STC2 has been
reported to play a protective role against oxidative stress or
hypoxia (Law and Wong, 2010; Kim et al., 2015). Both stressing
conditions evoke the accumulation of unfolded proteins in the
ER leading to the activation of the unfolded protein response
(UPR) to which STC2 belongs (Ito et al., 2004). Ca2+ mobilizing
agents, such as thapsigargin (TG) and Ca2+ ionophores, have
been found to activate UPR in culture cells (Ito et al., 2004),
thus promoting the transcription of a variety of genes, including
NUCB2, ATP2A2, CGRP2, and STC2 (Ito et al., 2004). In mouse
embryonic fibroblasts STC2 overexpression results in reduced
SOCE probably mediated by interaction with STIM1 (Zeiger
et al., 2011), which strongly suggests a possible role for STC2 in
the regulation of SOCE. We have recently reported that STC2 is
expressed in human andmouse platelets (Lopez et al., 2017). Here
we provide for the first time evidence for a role of STC2 in the
regulation of Ca2+ entry and aggregation in mouse platelets. Our
results indicate that in STC2-deficient mice thrombin-stimulated
platelet aggregation and Ca2+ mobilization is enhanced, which
might be associated to the overexpression of Orai3 channels.
MATERIALS AND METHODS
Materials
Fura-2/AM was from Invitrogen Molecular probes (California,
USA). Mouse anti-STIM1 [Clone 44 Clone 44–GOK
(RUO)] antibody was from BD Biosciences R© (Madrid,
Spain). Rabbit polyclonal anti-TRPC1 (against peptide
QLYDKGYTSKEQKDC) antibody was supplied by OriGene R©
(Rockville (MD) USA). Anti-TRPC6 extracellular antibody was
from Alomone (Jerusalem, Israel). Anti-TRPC3 was from Abcam
(Cambridge, UK). Mouse and rabbit HRP-conjugated secondary
antibodies were from Jackson Immunoresearch R© (West Grove,
PA, USA). Rabbit polyclonal anti-Orai1 (against sequence
amino acids 288–301) antibody, anti-Orai3 antibody, anti-actin
antibody, thrombin (Thr), ADP, thapsigargin (TG), 1-oleoyl-
2-acetyl-sn-glycerol (OAG), apyrase, aspirin, as well as other
reagents of analytic grade were purchased from Sigma-Aldrich R©
(Madrid, Spain).
Animals
C57BL/6J WT mice were provided by Harlam R©, while C57BL/6J
STC2−/− mice were kindly provided by Dr. Roger Reddel from
the Children’s Medical Research Institute (CMRI) (Australia)
(Chang et al., 2008). Animals were breed under controlled
environmental conditions (25◦C), which consisted on a regular
12 h light-dark photoperiod and free access to drink and food.
The two mice conolies were bred separately, and after two or
three generations, animals were backcrossed in order tominimize
genetic drift. STC2 deficiency was regularly assessed by PCR and
Western blotting. Mice of age range between 8 and 10 weeks were
bled three times under isoflurane anesthesia, leaving a resting
period of a week between each extraction.
All procedures were performed in agreement with the
Helsinki Declaration, the guidelines from the Council of Europe
N◦ 123 (Strasbourg, 1985) and have been approved by the Local
Ethical Committee.
Tail Bleeding
Anesthetized animals were subjected to surgical sectioning
of the tip of the tail (sections of 1–4mm were cut off,
approximately), and a whatman filter paper was imbibed with
the blood at regularly periods of 30 s until the bleeding stopped
(Vermeersch et al., 2017). In case of excessive bleeding, lasting
more than 25min, the experiments were artificially interrupted
by cauterizing the injury. Average of the bleeding time was
considered in these experiments, and the possible differences
between WT and STC2-deficient mice were analyzed.
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Blood Extraction Procedures and Platelet
Isolation
Isoflurane anesthetized mice were bled from the retroorbital
plexus (Berna-Erro et al., 2014), and the blood was mixed
with 300 µL of acid citrate dextrose buffer containing: 85mM
sodium citrate, 78mM citric acid, 111mM glucose, pH 7.3.
Blood was centrifuged at 300 × g for 5min, and upon collected
the supernatants, they were centrifuged again at 100 × g
for 5min in order to obtain the platelet-rich plasma (PRP).
PRP was supplemented with aspirin (100µM) and apyrase
(40 U/mL) (except those used for aggregation, to which only
apyrase was added), and PRP was centrifuged again at 600 × g
for 5min. The pellet was suspended in Ca2+-free Tyrode’s
buffer containing: NaCl 137mM, KCl 2.7mM, NaHCO3
12mM, NaH2PO4 0.43mM, Glucose 0.1%, HEPES 5mM, BSA
0.35%, MgCl2 1mM, pH 7.13 and supplemented with apyrase
(40µg/mL).
Platelet Aggregation
Platelet aggregation was monitored using a Cronologh R©
aggregometer according to the protocols described elsewhere
(Lopez et al., 2013a). Briefly, isolated platelets were suspended
in fresh-Tyrode’s buffer containing 40 U/mL of apyrase. At
the moment of the experiment 1mM CaCl2 was added and
following aggregation was stimulated by using physiological
agonists such as thrombin (Thr, 0.1 U/mL) and ADP (100µM).
Percentage of aggregation at two different time points (3
and 8min after stimulation with Thr, and 4 and 10min
after treatment with ADP) as well as the percentage of the
slope (in case of Thr) and percentage of delay time to
initiate the irreversible phase of aggregation (in case of ADP)
were used to compare platelet aggregability in both mice
strains.
[Ca2+]c Determination
Platelets suspended in Tyrode’s buffer were loaded with fura-
2 by incubating for 30min at room temperature with fura-
2/AM (2µM) (Lopez et al., 2013b; Berna-Erro et al., 2014).
Fluorescence was recorded from aliquots of magnetically
stirred platelet suspensions at 37◦C using a fluorescence
spectrophotometer (RF-5301PC, Shimadzu Corporation, Kyoto,
Japan) with excitation wavelengths of 340 and 380 nm and
emission at 505 nm. Changes in [Ca2+]c were monitored using
the fura-2 340/380 fluorescence ratio and calibrated according
to the method of Grynkiewicz and coworkers (Grynkiewicz
et al., 1985). Thr-, OAG- and TG-evoked Ca2+ mobilization was
estimated as the integral of the rise in [Ca2+]c above basal for
2½ min after the addition of the stimuli, taking a sample every
second and expressed as nM•s (Lopez et al., 2005). To calculate
the initial rate of Ca2+ elevation after the addition of TG to the
medium, the traces were fitted to the equation y=A+KX, where
K is the slope (Redondo et al., 2003).
Immunoprecipitation and Western Blotting
Murine platelets were either mixed with RIPA (pH 7.2,
containing 474mM NaCl, 30mM Tris, 3mM EGTA, 0.3% SDS,
3% sodium deoxycholate, 3% triton X-100, 3mM Na3VO4
and protease inhibitors) or Laemmli’s buffer as required
(Alcaraz et al., 1990; Karlsson et al., 1994). Platelet samples
in RIPA were immunoprecipitated by incubation with 2µg/mL
of anti-Orai1 and anti-STIM1, and protein A-agarose beads
overnight at 4◦C. The immunoprecipitates were resolved by
10% SDS/PAGE, and separated proteins were electrophoretically
transferred onto nitrocellulose membranes using a semi-dry
blotter (for 2 h at 0.8 mA/cm2; Hoefer Scientific, Newcastle
under-Lyme, U.K.). Blots were incubated overnight with 10%
(w/v) BSA in Tris-buffered saline with 0.1% Tween 20 (TBST)
to block residual protein-binding sites. Detection of STIM1,
Orai1, TRPC1, TRPC3, TRPC6, and Orai3 was achieved by
incubation for 1 h with anti-STIM1 antibody diluted 1:1,000
in TBST, for 2 h with anti-Orai1, anti-TRPC1, or anti-TRPC6
antibody diluted 1:500 in TBST, and overnight with anti-TRPC3
or anti-Orai3 antibody diluted 1:1,000 and 1:250 in TBST,
respectively. To detect the primary antibody, membranes were
incubated with the appropriate secondary antibody (diluted
either 1:5,000 or 1:10,000 in TBST for 1 h) washed six times
in TBST, and exposed to enhanced chemiluminescence reagents
for 1min. Optical density of the bands was detected using
the C-Digit System (Licor R©, Spain), and differences between
samples were analyzed using the Image J software (N.I.H.
USA). Data are normalized using the amount of actin (for
Western blotting) or the result obtained after reprobing the
membranes with the immunoprecipitating antibody (for the
immunoprecipitations).
Statistical Analysis
Analysis of statistical significance was performed using the
Student’s unpaired t-test or one-way analysis of variance
(ANOVA) combined with the Dunnet’s post-test. The
significance level was P < 0.05.
FIGURE 1 | STC2 is involved in blood clotting. The tip of the tail of
anesthetized STC2-deficient (KO) and WT mice was sectioned as described in
Materials and Methods, and the bleeding time was determined. Box graph
represents mean ± SEM of 10 to 14 mice.
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RESULTS
STC2-Deficient Mice Exhibit Shorter
Bleeding Times
Wild type (WT) and STC2-deficient mice (KO) were subjected to
tail bleeding as described in the Material and Methods section.
As depicted in Figure 1, STC2−/− mice presented shorter mean
bleeding time than WT mice (5:10± 1:31 vs. 12:28± 2:40 min:s,
respectively; n = 10–14, P < 0,001). These findings suggest that
STC2 might play a role in the regulation of haemostasia.
STC2 Is Involved in Murine Platelet
Aggregation
We next explored the possible role of STC2 in platelets
aggregation. As depicted in Figure 2A, platelets from STC2-
deficient mice exhibited enhanced rate and amplitude of
aggregation in response to thrombin (Thr, 0.1 U/mL) compared
to WT. The percentage of aggregation was 50% and 70% at
3min, and 77% and 84% at 8min in WT and STC2-deficient
cells stimulated with Thr, respectively (P < 0,05); while the
slope was 75 and 95% at 3min and 63 and 71% at 8min
in platelets from WT and STC2-deficient mice, respectively.
Similarly, platelets from STC2−/− mice exhibited a significant
difference in the percentage of aggregation 4min after the
addition of the weak agonist, ADP (100µM; Figure 2B); while
10min after the addition of ADP a slightly greater percentage of
aggregation was still evident in STC2-defficientmice compared to
WTmice. As depicted in the aggregation traces of Figure 2B and
the below histogram (delay time), the initial phase of irreversible
aggregation occurred significantly earlier in platelets from STC2-
deficient mice, while the reversible aggregation almost occurred
simultaneously in both strains. These findings indicate a certain
degree of hyperactivity and hyperaggregability in platelets from
STC2-deficient mice, which is consistent with the reduced
bleeding time reported in Figure 1.
Platelets From STC2−/− Mice Presented
Altered Ca2+ Homeostasis
As previously described by others, platelet function is
regulated by several mechanisms, including intracellular Ca2+
mobilization. Hence, we have analyzed agonist-induced Ca2+
mobilization in platelets fromWT and STC2−/− mice. As shown
in Figure 3A, in the presence of 1mM extracellular CaCl2,
the integral of Thr-evoked Ca2+ mobilization, estimated as
described in Methods, in platelets from STC2-deficient mice was
308% greater than in platelets from WT mice (P < 0.001). Next,
we have explored the mechanism underlying the exacerbated
response to thrombin. First of all, we assessed Ca2+ release from
the TG-sensitive stores using the SERCA inhibitor thapsigargin
(TG), which induces passive Ca2+ efflux from the stores. The
FIGURE 2 | STC2 regulates platelet aggregation. Platelets drawn from WT (black traces) and STC2-deficient mice (gray traces) were isolated and suspended in
Tyrode’s buffer containing 1mM Ca2+ and then stimulated with Thr (A) or ADP (B). Aggregation of mice platelets was induced at a shear rate of 1,200 r.p.m. at 37◦C
in an aggregometer as described in the Materials and Methods section. Traces shown are representative of 14 separate experiments. Histograms represent the
percentage of aggregation and slope for Thr-induced platelet aggregation or the percentage of aggregation and delay time for ADP-evoked response expressed as
mean ± SEM. Delay time was presented as percentage of the value obtained in platelets from WT mice. *,**,***: represent P < 0.05, <0.01, and <0.001, respectively
as compared to the corresponding WT value.
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FIGURE 3 | STC2 negatively regulates calcium entry. (A) Fura-2-loaded platelets from WT and STC2-deficient mice were suspended in a medium containing 1mM
Ca2+ (A, C, and D) or in a Ca2+-free medium (75µM EGTA added; B). Cells were stimulated with Thr (A), TG (B,C) or OAG (D), as indicated. Calcium mobilization
was determined as described in Material and Methods. Traces are representative of 8-10 independent experiments. Bar graphs represent agonist-evoked Ca2+
mobilization expressed as the mean ± SEM and presented as the integral of the rise in [Ca2+]c above basal for 2½ min after the addition of the stimuli as described in
Material and Methods. **, ***, P < 0.01, and 0.001, respectively, as compared to the response in platelets from WT mice.
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treatment of mice platelets with 1µMTG in a Ca2+-free medium
resulted in a sustained increase in [Ca2+]c due to Ca
2+ release
from the internal stores. As shown in Figure 3B, TG-induced
response was 27% greater in STC2-deficient cells. Inhibition
of SERCA by TG reveals passive Ca2+ efflux from the ER,
an event that is influenced by both the Ca2+ gradient across
the ER membrane, which provides the driving force for Ca2+
efflux, and also the ER membrane permeability to Ca2+. As the
response to TG, estimated as the integral of the rise in [Ca2+]c
over the resting level for 2½ min after the addition of TG, was
found to be greater in STC2-deficient mice, thus suggesting
that these cells have a greater ability to store Ca2+, we have
further investigated the Ca2+ leakage rate in platelets from both
strains. Our results indicate that slope of the rise in [Ca2+]c upon
stimulation with TG was similar in platelets fromWT and STC2-
deficient mice (1.05 ± 0.27 and 1.34 ± 0.18 nM/s in platelets
from WT and STC2-deficient mice, respectively, P > 0.05;
n = 8), thus suggesting that the leakage rate is similar in both
strains.
Thr-evoked Ca2+-entry in human platelets mainly occurs
via two different pathways, SOCE and non-capacitative Ca2+
influx (Jardin et al., 2009). Hence, we have further explored
the mechanism involved in the exacerbated Thr mobilization
in platelets from STC2-deficient mice. SOCE was assessed by
depletion of the intracellular calcium stores using TG in the
presence of extracellular calcium. Our results indicate that TG-
evoked Ca2+ entry was significantly greater in STC2-deficient
cells (Figure 3C); however, the differences in SOCE in platelets
from both strains does not completely explain the magnitude
of the different Ca2+ entry evoked by Thr. Therefore, our
findings indicate that, in addition to the negative regulatory
role of STC2 in SOCE, previously documented by others and
confirmed by us in mice platelets, the exacerbated Thr-evoked
Ca2+ mobilization might involve the enhancement of non-
capacitative Ca2+ entry. To assess this possibility, platelets were
stimulated with the diacylglycerol analog, OAG, a selective
activator of non-capacitative Ca2+ entry channels (Hassock
et al., 2002; Berna-Erro et al., 2012). As depicted in Figure 3D,
treatment of platelets from WT mice with OAG (100µM)
in a medium containing 1mM CaCl2 resulted in a sustained
increase in [Ca2+]c. As expected, platelets from the STC2-
deficient mice exhibited a greater increase in [Ca2+]c in response
to OAG; while we did not detect changes in the resting
[Ca2+]c.
STC2 Modulates the Interaction Between
STIM1 and Orai1
Asmentioned above, SOCE requires physical interaction between
the ER sensor STIM1 and the Ca2+ channel Orai1. Previous
studies have revealed that STC2 regulates STIM1 expression
and function, and subsequently, negatively modulates SOCE.
Therefore, we have explored whether STC2 might be involved
in the interaction between STIM1 and Orai1. As depicted in
Figure 4, in platelets from STC2-deficient mice the interaction
between STIM1 and Orai1 in response to Thr was significantly
reduced. In addition, some authors have reported the existence
of the interaction between STIM1 and TRPC1 in the absence
of Orai1 in vascular smooth muscle cells. This mechanism was
elicited by activation of PLCβ1, which requires changes in the
[Ca2+]c (Shi et al., 2017). Previously, we have also demonstrated
interaction between STIM1 and TRPC1 in human platelets
(Lopez et al., 2006). In platelets from STC2-deficient mice we
FIGURE 4 | STC2 silencing impairs STIM1/Orai1 interaction. Murine platelets drawn from STC2-deficient (KO) and WT mice were either left untreated (R) or stimulated
for 1min with Thr (0.1 U/mL), and then lysed. Samples were then subjected to immunoprecipation using an anti-Orai1 or anti-STIM1 antibody, and subsequent
Western blotting was performed using anti-STIM1 and anti-TRPC1 antibodies, as indicated. Membranes were reprobed with the immunoprecipitating antibody for
protein loading control. Bottom panels, Platelet lysates from WT and STC2-deficient (KO) mice were subjected to Western blotting with anti-STIM1, anti-Orai1 or
anti-TRPC1 antibody, as indicated. Membranes were reprobed with an anti-actin antibody as loading control. Blots are representative of 8-12 separate experiments.
Bar graph represents Orai1-STIM1 coupling expressed as the mean ± SEM of the optical density in a.u. **P < 0.01 as compared to the response in resting platelets.
$$$P < 0.001 as compared to Thr-induced Orai1-STIM1 association in WT mice.
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FIGURE 5 | STC2 silencing upregulates Orai3 expression. Platelet lysates from WT and STC2-deficient (KO) mice were subjected to Western blotting with
anti-TRPC3, anti-TRPC6 or anti-Orai3 antibody, and reprobed with anti-actin antibody, as indicated. Blots are representative of 6 separate experiments. Bar graph
represents TRPC3, TRPC6 or Orai3 expression as the mean ± SEM of the optical density in a.u. **P < 0.01 as compared to the expression in platelets from WT mice.
have detected a 10% increase in the interaction between STIM1
and TRPC1 over the resting level after stimulation with Thr;
therefore, a detectable interaction between STIM1 and TRPC1
takes place in platelets from STC2-deficient mice (see right
hand side image of Figure 4). Furthermore, no differences were
detected in the expression of the components of the SOCE
Frontiers in Physiology | www.frontiersin.org 7 March 2018 | Volume 9 | Article 266
López et al. Role of STC2 in Platelets
mechanism in the platelet of STC2-deficient mice compared to
those of WT. Therefore, Thr-evoked Ca2+ entry might involve
STIM1-TRPC1 interaction in platelets from STC2-deficient
mice.
STC2 Modulates the Expression of Orai3 in
Mouse Platelets
In an attempt to assess the mechanism underlying the increase
in non-capacitative Ca2+ entry in platelets from STC2-deficient
mice, we have analyzed the expression of the non-capacitative
channels at the protein level in the platelets of both strains.
Previous studies have reported that TRPC3, TRPC6 and Orai3
are involved in non-capacitative entry (Berna-Erro et al., 2012;
Harper et al., 2013). Hence, we have examined the expression
of these channels in platelet lysates from WT and STC2-
deficient mice by Western blotting using specific antibodies.
As depicted in Figure 5, Western blotting of platelet lysates
with anti-TRPC3 or anti-TRPC6 antibodies revealed that the
expression of these proteins is not altered in the platelets of
STC2-deficient mice with respect to WT. Interestingly, our
results indicate that Orai3 expression is enhanced by 75% in
platelets from STC2−/− mice as detected by Western blotting
with the anti-Orai3 antibody. This finding strongly suggests that
STC2modulates Orai3 expression inmice platelets. Furthermore,
this observation might provide a mechanism for the enhanced
non-capacitative Ca2+ influx in platelets from STC2-deficient
mice.
DISCUSSION
Here we provide for the first time evidence supporting
a role for STC2 in platelet aggregation and haemostasis.
Using the murine model lacking STC2, we have found that
these mice exhibited enhanced platelet response to strong
and weak agonists, such as thrombin and ADP, respectively,
and subsequently reduced bleeding time. Our results indicate
that STC2 might modulate platelet aggregation through the
regulation of Ca2+ homeostasis in these cells, as it was
previously reported in other mammal cells (Zeiger et al.,
2011). We have found that platelets from STC2-deficient mice
exhibit a greater ability to store Ca2+ in the ER, although
the leakage rate across the ER membrane is not significantly
enhanced. Furthermore, our results indicate that STC2 modulate
agonist-induced Ca2+ entry, so that the deficiency of STC2
results in exacerbated Ca2+ signals and, most likely, platelet
hyperaggregability.
Thrombin evokes Ca2+ influx in platelets via SOCE and non-
capacitative Ca2+ entry (Jardin et al., 2009). Our results indicate
that STC2 plays a role supporting stimulated STIM1/Orai1
interaction, as Thr was unable to enhance STIM1/Orai1
association in platelets from STC2 KO mice. Although we have
found a detectable increase in the STIM1-TRPC1 interaction
upon stimulation with Thr, our findings indicate that it is
unlikely that SOCE is enhanced, and, therefore, the enhanced
Ca2+ influx induced by Thr in platelets from STC2-deficient
mice is more likely mediated by enhanced non-capacitative
Ca2+ entry. Our findings indicate that STC2 deficiency results
in an impaired STIM1/Orai1 interaction, but also we have
found that TG-induced Ca2+ entry in platelets from STC2 KO
mice is significantly enhanced. This apparent discrepancy might
be explained by the fact that TG has been found to activate
non-capacitative Ca2+ entry in platelets through the release of
autocrine factors (Harper et al., 2009); therefore, as for thrombin,
the enhanced Ca2+ entry induced by TG in platelets from
STC2-deficient mice might involve reduced SOCE and enhanced
non-capacitative Ca2+ entry. In support of this hypothesis, we
have found that non-capacitative Ca2+ entry evoked by OAG, a
diacylglycerol analog, is enhanced in STC2-deficient mice, which
provides evidence for a role of STC2 in the regulation of non-
capacitative Ca2+ influx in these cells. In murine platelets, two
main TRPC channels have been found to be activated in response
to OAG, TRPC3 and TRPC6 (Harper et al., 2013). However, we
have not detected significant changes in the protein expression of
TRPC3 or TRPC6 channels in platelet from STC2-deficient mice.
Orai3 has also been found to be involved in non-capactitative
Ca2+ entry (Berna-Erro et al., 2012), and we have found that
Orai3 expression is significantly enhanced in platelets from
STC2-deficient mice. Although we have not directly addressed
the involvement of Orai3 in Thr-induced non-capacitative Ca2+
entry, these findings suggest a possible mechanism for the
enhanced activation of non-capacitative Ca2+ entry in these cells.
The enhanced Orai3 expression in platelets from STC2-deficient
mice is unlikely to be responsible for the enhanced Ca2+ release
in response to TG, as a previous study has revealed that Orai3
is not involved in the TG-revealed ER Ca2+ leak (Leon-Aparicio
et al., 2017).
We have recently suggested that STC2 might be involved in
the pathophysiology of type 2 diabetes mellitus, where STC2 is
downregulated (Lopez et al., 2017). We have previously reported
that platelets from patients with type 2 diabetes mellitus exhibit
both hyperactivity and hyperaggregability (Saavedra et al., 2004;
Redondo et al., 2005; Lopez et al., 2013b). In the type 2 diabetic
patients we found that non-capacitative Ca2+ entry is enhanced,
while SOCEmight be attenuated (Jardin et al., 2009, 2011). These
findings resemble our current observations. Thus, our present
results might provide an explanation to the platelet complications
in diabetic patients as a reduction in STC2 expression might lead
to platelet hyperaggregability due to enhanced Orai3 expression,
although at present we cannot discard other possible mechanisms
for the increase in non-capacitative Ca2+ entry in these cells.
Summarizing, we provide for the first time evidence for a role
of STC2 in platelet aggregation through the modulation of Ca2+
homeostasis.
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